Equifax Inc. (LON:0II3)
240.52
-0.81 (-0.34%)
At close: Aug 1, 2025
Intra-Cellular Therapies Market Cap
Equifax has a market cap or net worth of 22.43 billion as of August 1, 2025. Its market cap has decreased by -8.97% in one year.
Market Cap
22.43B
Enterprise Value
26.08B
Revenue
4.26B
Ranking
n/a
PE Ratio
48.04
Stock Price
$240.52
Market Cap Chart
Since March 1, 1990, Equifax's market cap has increased from 749.67M to 22.43B, an increase of 2,891.90%. That is a compound annual growth rate of 10.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 22.43B | -11.07% |
Dec 31, 2024 | 25.22B | 5.44% |
Dec 29, 2023 | 23.92B | 21.11% |
Dec 30, 2022 | 19.75B | -25.13% |
Dec 31, 2021 | 26.38B | 53.54% |
Dec 31, 2020 | 17.18B | 34.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Rolls-Royce Holdings | 89.38B |
RELX PLC | 72.00B |
BAE Systems | 53.36B |
Experian | 36.52B |
Ashtead Group | 21.84B |
International Consolidated Airlines Group | 17.68B |
Halma | 12.28B |
Rentokil Initial | 8.72B |